Breast Imaging Sales

Breast Imaging Sales Market Outlook

The global breast imaging market is projected to reach approximately USD 4.5 billion by 2035, with a compound annual growth rate (CAGR) of around 6.2% during the forecast period of 2025 to 2035. This growth can be attributed to the increasing prevalence of breast cancer, ongoing technological advancements in imaging techniques, and rising awareness regarding early detection and diagnosis. Furthermore, the growing number of screening programs and government initiatives aimed at breast cancer awareness are also contributing factors driving the market's expansion. The shift towards personalized medicine and the integration of artificial intelligence in breast imaging processes are expected to significantly enhance the accuracy and efficiency of diagnosis, thus propelling market growth. Additionally, the increasing number of women participating in routine screening examinations will further boost demand in the coming years.

Growth Factor of the Market

The growth of the breast imaging market is significantly influenced by several key factors. The rising incidence of breast cancer globally is one of the primary drivers, with statistics indicating that one in eight women will be diagnosed with breast cancer in their lifetime. This alarming trend has led to a heightened focus on early detection, prompting healthcare providers to invest in advanced imaging technologies. Moreover, the introduction of more effective screening programs, alongside public awareness campaigns about the importance of regular breast examinations, has further stimulated the demand for specialized imaging services. Furthermore, advancements in imaging technologies, such as digital mammography and breast ultrasound, are improving the accuracy of diagnoses, leading to better patient outcomes and driving market growth. The integration of AI and machine learning into imaging procedures is also a critical factor, as these technologies enhance diagnostic capabilities and streamline workflows in clinical settings.

Key Highlights of the Market

• The breast imaging market is expected to exhibit steady growth driven by an increase in breast cancer prevalence.
• Technological advancements are leading to the development of more accurate and efficient imaging modalities.
• Public awareness campaigns are significantly contributing to the adoption of breast screening programs.
• The integration of AI in imaging technologies is expected to enhance diagnostic precision.
• The demand for breast imaging services is increasing among various end-users, including hospitals and specialized imaging centers.

By Product Type

Mammography Systems:

Mammography systems are the cornerstone of breast imaging, primarily used for the early detection of breast cancer. These systems utilize low-energy X-rays to capture detailed images of breast tissues, facilitating the identification of abnormalities. The market for mammography systems is witnessing significant growth due to the rising prevalence of breast cancer and the increasing adoption of screening programs worldwide. Technological advancements, such as digital mammography and 3D tomosynthesis, are enhancing image quality and diagnostic accuracy, making these systems more appealing to healthcare providers. Furthermore, the availability of portable mammography units is expanding access to screening in remote and underserved areas, contributing to market growth.

Breast Ultrasound Systems:

Breast ultrasound systems play a crucial role in complementing mammography, particularly for patients with dense breast tissues where mammograms may not provide conclusive results. These systems utilize sound waves to create images of the internal structures of the breast, allowing for the detection of cysts and solid masses. The increasing use of breast ultrasound for diagnostic purposes, especially in conjunction with mammography, is driving the growth of this segment. Additionally, advancements such as automated breast ultrasound systems are improving workflow efficiency and diagnostic accuracy, further propelling the adoption of these systems in clinical settings.

Breast MRI Systems:

Breast MRI systems are increasingly being utilized for high-risk patients and those with complex breast conditions that require detailed imaging. Magnetic Resonance Imaging (MRI) provides superior contrast resolution, allowing for comprehensive evaluation of breast tissues. The growing awareness of the benefits of MRI in breast cancer detection and staging is driving the adoption of breast MRI systems. Moreover, the implementation of contrast-enhanced MRI techniques is enhancing diagnostic capabilities, making it an essential tool in breast imaging. The market for breast MRI systems is anticipated to grow steadily as healthcare providers seek more effective means of diagnosing and monitoring breast cancer.

Breast CT Systems:

Breast Computed Tomography (CT) systems are emerging as an innovative modality in breast imaging, offering 3D imaging capabilities that surpass traditional mammography. Breast CT systems provide high-resolution images that allow for detailed examination of breast structures, aiding in the detection of abnormalities that may be missed by other imaging techniques. As the technology continues to evolve, the market for breast CT systems is expected to grow, driven by their potential to improve diagnostic accuracy and patient outcomes. Moreover, the incorporation of artificial intelligence in breast CT imaging is expected to enhance image analysis, further strengthening the market's growth prospects.

Nuclear Imaging Systems:

Nuclear imaging systems, including techniques like Positron Emission Tomography (PET), are gaining traction in breast imaging, particularly for assessing metastatic disease and monitoring treatment response. These systems utilize radioactive tracers to visualize metabolic processes in breast tissues, providing critical information for diagnosing and managing breast cancer. The increasing incorporation of nuclear imaging into routine breast cancer protocols is driving market growth. Furthermore, advancements in hybrid imaging technologies, such as PET/CT, are enhancing diagnostic accuracy and expanding the applications of nuclear imaging in breast cancer management, further contributing to the segment's growth.

By Modality

2D Mammography:

2D mammography remains the most widely used screening tool for breast cancer, offering a standard method for detecting abnormalities in breast tissues. This modality produces flat images of the breast and is instrumental in identifying tumors and calcifications. The ease of use and established protocols for 2D mammography contribute to its continued relevance in clinical practice. Despite advancements in technology, the simplicity and lower cost of 2D mammography ensure its sustained demand, particularly in regions where resources are limited. However, the limitations of this modality in detecting cancers in dense breast tissues have led to a gradual shift towards more advanced imaging techniques.

3D Tomosynthesis:

3D tomosynthesis, or digital breast tomosynthesis (DBT), represents a significant advancement in mammography, allowing radiologists to obtain a three-dimensional view of breast tissues. This modality captures multiple images from different angles, helping to reduce false positives and improve cancer detection rates, particularly in women with dense breast tissues. As awareness of the limitations of 2D mammography grows, the adoption of 3D tomosynthesis is on the rise, supported by favorable clinical outcomes and improved patient experiences. The increasing number of regulatory approvals for 3D tomosynthesis systems is further driving the growth of this segment in the breast imaging market.

Breast Ultrasound:

Breast ultrasound is commonly used as a supplementary tool to mammography for the evaluation of breast abnormalities. This modality is particularly effective for differentiating between solid masses and cysts and is often utilized for patients with dense breast tissues. The non-invasive nature of breast ultrasound, along with its lack of ionizing radiation, makes it a preferred choice for many healthcare providers. As technological advancements continue to improve image quality and diagnostic capabilities, the demand for breast ultrasound systems is expected to grow. Moreover, the increasing trend of using ultrasound in conjunction with mammography for better diagnostic accuracy is further driving market growth.

Breast MRI:

Breast Magnetic Resonance Imaging (MRI) is increasingly recognized for its role in the early detection and diagnosis of breast cancer, especially in high-risk populations. This modality provides detailed images of breast tissues, allowing for better assessment of tumors, particularly in cases where mammography results are inconclusive. The growing acceptance of breast MRI as a standard practice for certain patient demographics is bolstering market growth. Additionally, advancements in MRI technology, such as faster scanning times and improved imaging techniques, are enhancing its feasibility in clinical settings. The increasing number of clinical guidelines recommending breast MRI as part of the screening protocol for high-risk women is further supporting the expansion of this segment.

Molecular Breast Imaging:

Molecular breast imaging (MBI) is an emerging technique that utilizes radiotracers to visualize breast tissues at a molecular level. This modality is particularly beneficial for patients with dense breast tissues, where traditional imaging methods may be less effective. MBI offers higher sensitivity in detecting tumors and provides additional information on the biological characteristics of breast lesions. As healthcare providers seek more accurate and effective methods for breast cancer detection, the adoption of MBI is anticipated to rise. The ongoing research and clinical trials aimed at validating the efficacy of molecular breast imaging will further enhance its acceptance within medical practices, thereby driving market growth.

By User

Hospitals:

Hospitals serve as primary centers for breast imaging services, equipped with advanced diagnostic technologies to provide comprehensive care to patients. The demand for breast imaging in hospitals is fueled by the increasing number of patient referrals for screening and diagnostic procedures. Hospitals often have the resources to invest in cutting-edge imaging equipment, including mammography systems, MRI machines, and ultrasound devices. Furthermore, the integration of breast imaging services within hospitals facilitates multidisciplinary care, allowing for seamless collaboration between radiologists, oncologists, and surgeons. As patient awareness regarding breast cancer continues to rise, hospitals are expected to see sustained growth in breast imaging services.

Diagnostic Imaging Centers:

Diagnostic imaging centers specialize in providing advanced imaging services, making them a critical component of the breast imaging market. These centers often focus exclusively on imaging procedures, offering a range of modalities for breast cancer screening and diagnosis. The convenience and accessibility of diagnostic imaging centers attract patients seeking specialized care, as they often have shorter wait times compared to hospitals. Moreover, the increasing trend of outsourcing imaging services to specialized centers is driving growth in this segment. As healthcare providers seek to enhance patient outcomes and streamline workflows, the role of diagnostic imaging centers in breast imaging is becoming increasingly significant.

Breast Imaging Centers:

Breast imaging centers are dedicated facilities specializing in the diagnosis and treatment of breast conditions, making them vital players in the breast imaging market. These centers provide a focused approach to breast health, offering a comprehensive range of imaging services tailored specifically for women. The growing awareness of breast cancer and the importance of regular screenings have led to increased patient visits to breast imaging centers. Furthermore, the ability of these centers to provide specialized care, including counseling and follow-up services, enhances their appeal among patients. As the demand for targeted breast health services continues to rise, breast imaging centers are expected to see significant growth in their service offerings and patient volumes.

By Technology

Analog Imaging:

Analog imaging technology was once the standard in breast imaging, utilizing film-based systems to capture breast images. While this technology has been largely supplanted by digital methods, it continues to be used in certain settings due to its simplicity and lower initial investment costs. However, the limitations associated with analog imaging, such as lower image quality and longer processing times, have led to a gradual decline in its usage. As healthcare providers increasingly prioritize diagnostic accuracy and efficiency, the shift towards digital imaging technologies is expected to continue, further diminishing the market share of analog imaging.

Digital Imaging:

Digital imaging technology has revolutionized the field of breast imaging, offering significant advantages over traditional analog methods. Digital mammography allows for enhanced image quality, quicker processing times, and the ability to manipulate images for better visualization. The adoption of digital imaging has been driven by its superior capabilities in detecting abnormalities, resulting in more accurate diagnoses and improved patient outcomes. Additionally, the integration of digital imaging with advanced technologies such as computer-aided detection (CAD) systems is enhancing the screening process. The growing demand for high-quality imaging services is expected to propel the digital imaging segment further, solidifying its position as the dominant technology in the breast imaging market.

Contrast-Enhanced Spectral Mammography:

Contrast-enhanced spectral mammography (CESM) is an innovative technique that combines mammography with a contrast agent to improve visualization of breast lesions. This technology provides additional information about blood flow and vascularity within breast tissues, aiding in the differentiation of benign and malignant lesions. As the demand for accurate breast cancer diagnosis continues to rise, CESM is gaining traction among radiologists and healthcare providers. The potential for CESM to enhance sensitivity and specificity in breast imaging makes it a valuable tool in clinical practice. With ongoing research and clinical trials validating its efficacy, the adoption of contrast-enhanced spectral mammography is expected to grow significantly within the breast imaging market.

Automated Whole Breast Ultrasound:

Automated whole breast ultrasound (AWBU) is an advanced imaging technique that provides comprehensive coverage of breast tissues in a single examination. This modality is particularly beneficial for women with dense breast tissues, where traditional mammography may yield inconclusive results. AWBU offers a non-invasive and efficient approach to breast imaging, making it an attractive option for both patients and healthcare providers. The increasing recognition of the limitations of mammography in certain populations is driving the adoption of automated breast ultrasound systems. As more women seek regular screenings, the demand for AWBU is anticipated to rise, contributing to growth in the breast imaging market.

Breast Specific Gamma Imaging:

Breast Specific Gamma Imaging (BSGI) is a novel imaging modality that utilizes a gamma camera to capture detailed images of breast tissues after the administration of a radiotracer. This technique is particularly useful for detecting early-stage breast cancer and evaluating suspicious lesions identified by mammography. The high sensitivity of BSGI in imaging breast tissues makes it a valuable tool, especially for patients with dense breasts. The increasing emphasis on early detection and personalized cancer treatment is driving the demand for BSGI. As research continues to support its clinical applications, BSGI is expected to gain prominence in the breast imaging market, expanding the range of available diagnostic options.

By Region

The North American breast imaging market is one of the largest globally, driven by a combination of advanced healthcare infrastructure, high awareness of breast cancer screening, and technological advancements. The region is projected to account for approximately 45% of the global market share by 2035. With a CAGR of around 5.8% during the forecast period, North America is expected to continue leading in breast imaging innovations and adoption of advanced technologies such as 3D mammography and MRI systems. Additionally, government initiatives aimed at improving screening rates and access to care further bolster the market in this region. The presence of major healthcare players and consistent investments in research and development are key factors contributing to North America's dominant position in the breast imaging market.

In Europe, the breast imaging market is also experiencing significant growth, attributed to increasing investment in healthcare and a strong emphasis on early cancer detection. The European market is expected to hold approximately 30% of the global market share by 2035, with a projected CAGR of around 6.0%. Countries such as Germany, the UK, and France are leading in breast imaging services due to their advanced healthcare systems and proactive approaches to cancer screening. The European Union’s recommendations for regular mammography screening further enhance the market's growth prospects. As technological advancements continue to emerge and awareness campaigns promote breast health, Europe is likely to witness a robust increase in breast imaging services.

Opportunities

The breast imaging market presents numerous opportunities driven by advancements in technology and the growing focus on early detection of breast cancer. One significant opportunity lies in the integration of artificial intelligence and machine learning into imaging modalities. These technologies can enhance the accuracy of diagnoses, streamline workflow processes, and reduce the burden on radiologists. By automating certain tasks, AI can help healthcare professionals focus more on patient care and complex decision-making, ultimately improving patient outcomes. Moreover, the growing trend of personalized medicine is creating opportunities for the development of tailored imaging solutions that meet individual patient needs, further driving market growth.

Another promising opportunity for the breast imaging market arises from the increasing emphasis on breast cancer awareness and screening programs globally. As more women become educated about the importance of early detection, the demand for breast imaging services is expected to rise significantly. Additionally, the expansion of telemedicine and remote imaging services presents an opportunity to enhance access to breast imaging in underserved populations. By leveraging technology, healthcare providers can reach patients in remote areas and provide timely screenings, thereby improving overall breast health outcomes. Furthermore, ongoing research and development initiatives aimed at introducing innovative imaging techniques will continue to drive growth and create new opportunities in the breast imaging market.

Threats

The breast imaging market faces several threats that could hinder its growth trajectory. One of the primary concerns is the high cost associated with advanced imaging technologies, which can limit their accessibility, particularly in low-resource settings. Economic constraints faced by healthcare facilities may result in delayed adoption of new technologies, thereby affecting the quality of care provided to patients. Additionally, reimbursement challenges can also deter healthcare providers from investing in expensive imaging systems, further restricting patient access to essential screening services. The potential for regulatory hurdles and changes in government policies regarding breast imaging services may also pose challenges in the market. All these factors could potentially stymie the growth of the breast imaging market if not addressed effectively.

Another significant threat to the breast imaging market is the growing concern regarding the overdiagnosis and overtreatment of breast cancer. The increasing number of breast imaging procedures may lead to the detection of lesions that would not have resulted in clinical symptoms, causing anxiety and unnecessary interventions for patients. As awareness about this issue grows, patients and healthcare providers may become more cautious in recommending imaging procedures, potentially impacting overall screening rates. Furthermore, the advent of alternative screening methods and approaches may pose competitive threats to traditional imaging modalities. The need for continuous innovation and adaptation in breast imaging technologies is crucial to address these challenges effectively.

Competitor Outlook

• Hologic Inc.
• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Fujifilm Holdings Corporation
• Canon Medical Systems
• Carestream Health
• Hitachi Medical Systems
• Konica Minolta, Inc.
• Neusoft Medical Systems
• IQVIA
• Medtronic
• Radiology Partners
• United Imaging Healthcare
• Boston Scientific Corporation

The competitive landscape of the breast imaging market is characterized by a diverse range of players, from established multinational corporations to emerging startups. The market is driven by intense competition among key players striving to gain a competitive edge through innovation and technological advancements. Companies are investing heavily in research and development to introduce cutting-edge imaging solutions that enhance diagnostic accuracy and patient experience. Collaborations and partnerships between healthcare providers and imaging technology manufacturers are also becoming increasingly common, aimed at leveraging shared expertise to improve service delivery. Additionally, the focus on patient-centric solutions and personalized imaging approaches is leading to the development of new products and services tailored to specific patient demographics.

Among the leading companies in the breast imaging market, Hologic Inc. stands out as a pioneer, particularly in the field of 3D mammography. Hologic has been instrumental in advancing breast cancer screening technologies and offers a comprehensive suite of imaging solutions for both diagnostic and therapeutic purposes. GE Healthcare is another major player, renowned for its innovative imaging devices and software solutions designed to improve workflow efficiency in breast imaging. Siemens Healthineers also contributes significantly to the market with its advanced imaging technologies and commitment to enhancing patient care. The company's focus on integrating artificial intelligence into imaging processes is shaping the future landscape of breast imaging and improving diagnostic precision.

Philips Healthcare continues to make strides in the breast imaging market with its emphasis on advanced imaging modalities and patient-centric solutions. The company's commitment to merging technology with healthcare needs is evident in its product offerings, which include high-quality digital mammography systems and ultrasound technologies. Fujifilm Holdings Corporation is also a key player, recognized for its digital imaging solutions that enhance image quality and reduce radiation exposure. The company's innovative approach to breast imaging, coupled with its extensive experience in imaging technology, positions it favorably in the competitive landscape. As the breast imaging market evolves, these leading companies will play a critical role in driving innovation and shaping the future of breast cancer detection and management.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 IQVIA
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Hologic Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 GE Healthcare
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Carestream Health
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Philips Healthcare
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Radiology Partners
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Konica Minolta, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Siemens Healthineers
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Canon Medical Systems
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Hitachi Medical Systems
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Neusoft Medical Systems
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 United Imaging Healthcare
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Boston Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Fujifilm Holdings Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Breast Imaging Sales Market, By User
    • 6.1.1 Hospitals
    • 6.1.2 Diagnostic Imaging Centers
    • 6.1.3 Breast Imaging Centers
  • 6.2 Breast Imaging Sales Market, By Modality
    • 6.2.1 2D Mammography
    • 6.2.2 3D Tomosynthesis
    • 6.2.3 Breast Ultrasound
    • 6.2.4 Breast MRI
    • 6.2.5 Molecular Breast Imaging
  • 6.3 Breast Imaging Sales Market, By Technology
    • 6.3.1 Analog Imaging
    • 6.3.2 Digital Imaging
    • 6.3.3 Contrast-Enhanced Spectral Mammography
    • 6.3.4 Automated Whole Breast Ultrasound
    • 6.3.5 Breast Specific Gamma Imaging
  • 6.4 Breast Imaging Sales Market, By Product Type
    • 6.4.1 Mammography Systems
    • 6.4.2 Breast Ultrasound Systems
    • 6.4.3 Breast MRI Systems
    • 6.4.4 Breast CT Systems
    • 6.4.5 Nuclear Imaging Systems

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Breast Imaging Sales Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Breast Imaging Sales market is categorized based on

By Product Type

• Mammography Systems
• Breast Ultrasound Systems
• Breast MRI Systems
• Breast CT Systems
• Nuclear Imaging Systems

By Modality

• 2D Mammography
• 3D Tomosynthesis
• Breast Ultrasound
• Breast MRI
• Molecular Breast Imaging

By User

• Hospitals
• Diagnostic Imaging Centers
• Breast Imaging Centers

By Technology

• Analog Imaging
• Digital Imaging
• Contrast-Enhanced Spectral Mammography
• Automated Whole Breast Ultrasound
• Breast Specific Gamma Imaging

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Hologic Inc.
• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Fujifilm Holdings Corporation
• Canon Medical Systems
• Carestream Health
• Hitachi Medical Systems
• Konica Minolta, Inc.
• Neusoft Medical Systems
• IQVIA
• Medtronic
• Radiology Partners
• United Imaging Healthcare
• Boston Scientific Corporation